These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

134 related articles for article (PubMed ID: 6998820)

  • 21. Requirement for calcium ion in insulin secretion by the perfused rat pancreas.
    Curry DL; Bennett LL; Grodsky GM
    Am J Physiol; 1968 Jan; 214(1):174-8. PubMed ID: 4863806
    [No Abstract]   [Full Text] [Related]  

  • 22. Synthesis and release of proinsulin and insulin by isolated rat islets of Langerhans.
    Tanese T; Lazarus NR; Devrim S; Recant L
    J Clin Invest; 1970 Jul; 49(7):1394-404. PubMed ID: 4914679
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Interrelationship between glucagon and insulin release from isolated islets of Langerhans.
    Vance JE; Buchanan K
    Diabetes; 1968; 17():311-2. PubMed ID: 4870777
    [No Abstract]   [Full Text] [Related]  

  • 24. Cyclosporine inhibition of insulin secretion: effect of tolbutamide and extracellular calcium concentration.
    Bartlett ST; Gillison SL; Curry DL
    Transplant Proc; 1990 Apr; 22(2):749-53. PubMed ID: 2183445
    [No Abstract]   [Full Text] [Related]  

  • 25. Insulin release from monolayer cultures of rat pancreatic cells: a preliminary characterization.
    Marliss EB; Blondel B; Lambert AE; Stauffacher W
    Isr J Med Sci; 1972 Jun; 8(6):756-7. PubMed ID: 4559416
    [No Abstract]   [Full Text] [Related]  

  • 26. Defective insulin secretion in the N.Z.O. mouse: in vitro studies.
    Larkins RG
    Endocrinology; 1973 Nov; 93(5):1052-6. PubMed ID: 4591651
    [No Abstract]   [Full Text] [Related]  

  • 27. [Effect of adenosine triphosphate (ATP) on the secretion of insulin induced by tolbutamide in the absence of glucose].
    Chapal J; Roye M; Loubatières-Mariani MM
    C R Seances Soc Biol Fil; 1980; 173(6):1120-3. PubMed ID: 6446366
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Long-term actions of sulfonylureas on (pro-) insulin biosynthesis and secretion: I. Lack of evidence for a compensatory increase in (pro-) insulin biosynthesis after exposure of isolated pancreatic rat islets to tolbutamide and glibenclamide in vitro.
    Schatz H; Steinle D; Pfeiffer EF
    Horm Metab Res; 1977 Nov; 9(6):457-65. PubMed ID: 412764
    [No Abstract]   [Full Text] [Related]  

  • 29. Modulation of insulin secretion by cyclic AMP and prostaglandin E: the effects of theophylline, sodium salicylate and tolbutamide.
    Metz S; Fujimoto W; Robertson RP
    Metabolism; 1982 Oct; 31(10):1014-22. PubMed ID: 6290835
    [No Abstract]   [Full Text] [Related]  

  • 30. Insulin release by isolated pancreatic islets of the mouse incubated in vitro.
    Coll-Garcia E; Gill JR
    Diabetologia; 1969 Apr; 5(2):61-6. PubMed ID: 4313804
    [No Abstract]   [Full Text] [Related]  

  • 31. Differences in K+ permeability between cultured adult and neonatal rat islets of Langerhans in response to glucose, tolbutamide, diazoxide, and theophylline.
    Boschero AC; Tombaccini D; Carneiro EM; Atwater IJ
    Pancreas; 1993 Jan; 8(1):44-9. PubMed ID: 8419908
    [TBL] [Abstract][Full Text] [Related]  

  • 32. [Stimulation of insulin secretion by tolbutamide. Studies on experimental diabetes].
    Ammon HP
    Arzneimittelforschung; 1973 Nov; 23(11):Suppl:1675-6. PubMed ID: 4150009
    [No Abstract]   [Full Text] [Related]  

  • 33. Autocrine action of PACAP in islets augments glucose-induced insulin secretion.
    Yada T; Sakurada M; Nakata M; Shioda S; Yaekura K; Kikuchi M
    Ann N Y Acad Sci; 1998 Dec; 865():451-7. PubMed ID: 9928048
    [No Abstract]   [Full Text] [Related]  

  • 34. Reversible inhibition by hyaluronidase of the insulinotropic action of tolbutamide in isolated hamster pancreatic islets.
    Macchi IA; Zeytinoğlu FN; Beaser SB
    Proc Soc Exp Biol Med; 1974 Feb; 145(2):500-3. PubMed ID: 4360641
    [No Abstract]   [Full Text] [Related]  

  • 35. [Effects of increasing concentrations of glucose on insulin secretion. Synergy between glucose and hypoglycemic sulfonamides].
    Loubatières A; Mariani MM; Chapal J
    C R Seances Soc Biol Fil; 1968; 162(8):1575-80. PubMed ID: 4238184
    [No Abstract]   [Full Text] [Related]  

  • 36. Phosphoinositide hydrolysis and insulin secretion in response to glucose stimulation are impaired in isolated rat islets by prolonged exposure to the sulfonylurea tolbutamide.
    Zawalich WS
    Endocrinology; 1989 Jul; 125(1):281-6. PubMed ID: 2544404
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Mechanism by which cyproheptadine inhibits insulin secretion.
    Donatsch P; Lowe DA; Richardson BP; Taylor P
    Br J Pharmacol; 1980 Nov; 70(3):355-62. PubMed ID: 7002245
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Resistance to aminooxyacetate of the ionic response to tolbutamide in pancreatic islets.
    Lebrun P; Malaisse WJ; Herchuelz A
    Horm Metab Res; 1984 Jun; 16(6):322-4. PubMed ID: 6094326
    [No Abstract]   [Full Text] [Related]  

  • 39. Effect of tolbutamide on aminophylline-, 3,5-AMP-dibutyrate- or glucagon-induced insulin release from pancreatic islets after impairment of pyridine nucleotide metabolism caused by 6-aminonicotinamide (6-AN).
    Ammon HP
    Naunyn Schmiedebergs Arch Pharmacol; 1975; 290(2-3):251-64. PubMed ID: 241943
    [TBL] [Abstract][Full Text] [Related]  

  • 40. The effect of tolbutamide and glibenclamide on the incorporation of ( 3 H)leucine and on the conversion of proinsulin to insulin in isolated pancreatic islets.
    Schatz H; Maier V; Hinz M; Nierle C; Pfeiffer EF
    FEBS Lett; 1972 Oct; 26(1):237-40. PubMed ID: 4629118
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.